Abstract
Preferences in clinical trials can help researchers understand which aspects of treatments patients or other stakeholders value most, and their perceptions of benefit-risk trade-offs for a treatment. They can also be used to adjust outcomes for preference biases, increasing outcome precision. The aim of the study was to identify the extent to which oncology trials capture treatment preferences (TP).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
